VIRA Viratech Corporation (PK)

VIRATECH
ANNOUNCES JOINT VENTURE
WITH NANOBEAK FOR DETECTION OF CANCER AND DISEASES WITH NASA

 

STOCKTON, CALIFORNIA / June 3, 2013
/ Newswire/ -- Viratech Corp. (OTC: VIRA), the first open source biotech
research social network platform announced today the signing of a letter of
intent for a Joint Venture with California based Nanobeak Inc. to further
develop NASA device to detect Volatile Organic Compounds (?VOC?s?) in breath
tests that may be associated with infectious diseases, cancer, and other medical
problems for screening purposes.  The device currently in existence is about the
size of a postage stamp and plugs into a cell phone to collect, process, and
transmit the testing data to anywhere in the world.

Dr. Kevin Buckman, the CEO of Viratech
states, ?The System is based on a proven vapor phase sensor for known molecules
present in the breath of individuals and fully integrated with a smart phone
app. It is capable of being interfaced with disease experts in a global
network.?  Dr. Buckman has written a book
called, ?Breath Analysis,? and is also an expert on the need for Point of Care
testing in third world countries and here domestically. 

 

This
technology, originally developed by NASA to identify biomarkers exhaled by
astronauts in space flight has now been developed for VOC screening to be both medically
effective and affordable,? according to Dr. Buckman. 

 

Viratech?s future goals include testing
using the same handheld system for possible detection VOC?s associated with TB
infections, cancer, and other diseases.   

 

About
Viratech Corp and Cancer.im

 

Viratech Corp. has created the first
open source biotech research social network platform. The purpose of the
platform is to make it possible for individuals or smaller companies to compete
with larger companies in the race to patent new medicines or technology.

 

Viratech?s subsidiary, Cancer.im, Inc.,
owns and operates http://cancer.im, a social
network resource site for cancer patients, survivors, advocates and
volunteers.  Cancer.im harnesses social
collaboration utilities to develop what Viratech believes will become the first
experience-based search engine powered by social collaboration. 

 

Forward-Looking
Statements:

 

We caution that this forward-looking
information is inherently uncertain and actual results may differ. 

 

Contact:
Dr. Kevin Buckman

Viratech,
Corp.

http://viratech.org

Email Contact: info@viratech.org